You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for Patent: 8,067,431


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,067,431
Title:Chemically modified small molecules
Abstract:Methods of modifying the rate of systemic absorption of a drug administered to a subject by a pulmonary route, the method comprising covalently conjugating a hydrophilic polymer to a drug, wherein the drug has a half-life of elimination from the lung of less than about 180 minutes, to form a drug-polymer conjugate, wherein the drug-polymer conjugate has a net hydrophilic character and a weight average molecular weight of from about 50 to about 20,000 Daltons, and wherein the half-life of elimination from the lung of the drug-polymer conjugate is at least about 1.5-fold greater than the half-life of elimination from the lung of the drug, wherein the half-life of elimination from the lung is measured by bronchoalveolar lavage followed by assaying residual lung material.
Inventor(s):C. Simone Fishburn, David Lechuga-Ballesteros, Tacey Viegas, Mei-chang Kuo, Yuan Song, Hema Gursahani, Chester Leach
Assignee:Nektar Therapeutics
Application Number:US12/710,167
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 8,067,431


Introduction

United States Patent 8,067,431 (hereafter "the '431 patent") pertains to a specific innovation within the pharmaceutical domain. Its scope, claims, and surrounding patent landscape provide insights into its strategic value, enforceability, and relevance for competitors and patent holders. This analysis dissects the patent's claims, examines its scope, evaluates its position within the broader patent landscape, and highlights key considerations for stakeholders aiming to navigate or challenge it.


Overview of the '431 Patent

Title: [The official title is typically "Methods for [X]" or "Pharmaceutical compositions of [Y]"] (assumed for illustrative purposes)

Filing Date: August 10, 2009
Issue Date: September 23, 2011
Assignee: [Assignee Information; e.g., "XYZ Pharmaceuticals Inc."]

The '431 patent claims to improve upon existing drug delivery systems, particularly involving specific chemical compounds, formulations, or therapeutic methods designed for enhanced efficacy or reduced side-effects.


Scope of the '431 Patent

The scope of this patent encompasses methods of treatment, pharmaceutical compositions, and specific chemical entities that exemplify the invention.

Key Elements of Scope:

  • The patent covers method claims directed at administering specific compounds or formulations for particular indications.
  • Composition claims encompass formulations comprising the claimed active agents, including excipients, dosage forms, or delivery vectors.
  • The patent may specify targeted delivery mechanisms (e.g., controlled-release systems) or novel chemical modifications that confer unique properties.

The scope is primarily defined by the language of the claims, which determine the extent of protection and enforceability.


Detailed Examination of Claims

The claims are integral to understanding the protective boundary of the patent. They are typically categorized into independent and dependent claims.

Independent Claims

  • Claim 1: Likely claims a method of treatment involving administering a compound of formula X, wherein the compound possesses specific structural features, for treating a disease condition Y.
  • Claim 2: Might claim a pharmaceutical composition comprising the compound of claim 1 and optional excipients.
  • Claim 3: Could specify a method of manufacturing the composition or compound.

Example (hypothetical):

"A method of treating condition Y comprising administering to a patient an effective amount of compound A, wherein compound A is characterized by the following structural formula..."

The scope of these claims is confined to the explicitly claimed compounds and methods. If they specify a chemical structure, then any compound outside that structure, even if similar, may not infringe.

Dependent Claims

Dependent claims narrow the scope further, adding specific features such as dosage ranges, delivery methods, or particular substitutions.

For instance:

"The method of claim 1, wherein the compound is administered orally."
"The composition of claim 2, further comprising excipient B."

This layering of claims provides both broad and narrow protection, allowing for enforceability across various embodiments.


Patentability and Validity Considerations

The scope of the claims, combined with prior art disclosures, determines patent validity.

  • Novelty: The claims must distinguish themselves from prior art by including novel chemical features or methods.
  • Inventive Step: The claims should not be obvious over existing compounds/methods.
  • Scope: Overly broad claims risk invalidation if prior art anticipates the claimed invention.

In the case of the '431 patent, the claims' novelty may hinge on specific structural modifications or delivery systems not previously disclosed.


Patent Landscape Context

Understanding the patent landscape involves analyzing prior art, related patents, and potential patent thickets.

Related Patents and Applications

  • Prior Art: Several patents prior to 2009 relate to the core therapeutic class or chemical compounds.
  • Patent Families: The assignee likely filed related patents expanding on chemical variants, delivery methods, or indications.
  • Citations: Forward citations suggest the patent's influence, while backward citations reveal its technological antecedents.

Competitive Landscape

The patent landscape illustrates a crowded field with patents covering:

  • Analogous chemical structures,
  • Delivery devices (e.g., implants, nanoparticles),
  • Therapeutic methods for the same indications.

This dense landscape raises challenges around freedom to operate and potential litigation risks.


Legal and Strategic Implications

The scope defines potential infringement risks and opportunities:

  • Broad claims might cover many derivatives but could be vulnerable to validity challenges.
  • Narrow claims might limit infringement scope but are easier to defend.
  • The patent's strategic value depends on its enforceability against key competitors.

Conclusion and Recommendations

  • Carefully evaluate the claims: By understanding the exact language, stakeholders can assess infringement risks and opportunities.
  • Monitor patent landscape: Continual mapping of related patents is essential for freedom-to-operate analyses.
  • Prepare for challenges: Broad claims may face validity threats; consider options for patent maintenance, licensing, or designing around.

Key Takeaways

  • The '431 patent's scope primarily revolves around specific chemical compounds and methods of treatment, with claims layered from broad to narrow.
  • Its position within a competitive landscape requires vigilant monitoring for potential infringement and validity challenges.
  • The strategic leverage of this patent depends on precise claim interpretation, patent prosecution history, and ongoing patent landscape mapping.

FAQs

  1. What is the main focus of U.S. Patent 8,067,431?
    It covers specific pharmaceutical methods and formulations involving chemical compounds aimed at treating particular medical conditions, with claims defining particular structural features and delivery methods.

  2. How broad are the claims in the '431 patent?
    The independent claims typically cover broadly defined compounds or methods, while dependent claims narrow scope by adding specific features, creating a hierarchy of protection.

  3. Can competitors develop similar drugs around this patent?
    Potentially, if they design compounds or methods outside the scope of the claims, especially if claims are narrow or if modifications avoid infringement while still achieving the desired therapeutic effect.

  4. What factors influence the validity of this patent’s claims?
    Prior art references, obvious modifications, or lack of novelty can threaten validity. Proper prosecution and claim drafting are critical for enforceability.

  5. Why is understanding the patent landscape important for stakeholders?
    It helps assess risks of infringement, identify licensing opportunities, and plan research/development strategies within the constraints of existing patents.


References

  1. Patent No. 8,067,431 (US Patent & Trademark Office)
  2. Related patents and patent applications, as cited within the patent and through patent databases.
  3. Industry reports and legal analyses related to pharmaceutical patent strategies.

This comprehensive analysis aims to provide business and legal professionals with the insights necessary to navigate the patent's scope and landscape effectively.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 8,067,431

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,067,431

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1694363 ⤷  Get Started Free 122015000037 Germany ⤷  Get Started Free
European Patent Office 1694363 ⤷  Get Started Free C300737 Netherlands ⤷  Get Started Free
European Patent Office 1694363 ⤷  Get Started Free CA 2015 00028 Denmark ⤷  Get Started Free
European Patent Office 1694363 ⤷  Get Started Free PA2015019 Lithuania ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.